AMBBY (Ambu AS) Research & Development: $56.9 Mil (TTM As of Mar. 2026)


AMBBY Ambu AS AMBBY
84 GF Score
Price $9.43
GF Value $19.37
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Research & Development?

Ambu AS AMBBY +10.36% 84 Research & Development is $56.9 Mil as of Mar. 2026. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.37 (Significantly Undervalued).

Research & Development is the aggregate amount of research and development expenses during the year. Ambu AS's Research & Development for the three months ended in Mar. 2026 was $14.1 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $56.9 Mil.

Ambu AS  (OTCPK:AMBBY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ambu AS Research & Development Related Terms

Ambu AS Research & Development Historical Data

* Premium members only.

The historical data trend for Ambu AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Research & Development Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.60 37.38 42.22 48.38 54.57

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.76 13.45 14.63 14.74 14.08
AMBBY
84GF Score
Ambu AS AMBBY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $56.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $56.9 Mil mean?
Ambu AS (AMBBY) has a Research & Development of $56.9 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Ambu AS and its competitors.
Is Ambu AS's Research & Development too high?
Ambu AS's current Research & Development is $56.9 Mil. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Research & Development compare to ABT and SYK?
Ambu AS's Research & Development of $56.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ambu AS and its competitors. Ambu AS's current Research & Development is $56.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.37, compared to a current price of $9.43 — trading 51.3% below its estimated fair value. The current Research & Development is $56.9 Mil. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ambu AS (AMBBY), the current Research & Development is $56.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (AMBBY) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of $9.43 is trading 51.3% below its estimated GF Value™ of $19.37. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for AMBBY:

  • Research & Development: $56.9 Mil
  • GF Value™: $19.37 vs. price of $9.43 (51.3% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score

Get the complete analysis for AMBBY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.43
Price
$19.37
GF Value